Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
02/2012
02/08/2012CN102348703A Compounds for the treatment of metabolic disorders
02/08/2012CN102348697A 磺酰胺衍生物 Sulfonamide derivatives
02/08/2012CN102348682A 1,1,1-trifluoro-2-hydroxypropyl compounds
02/08/2012CN102344398A 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
02/08/2012CN101982468B 噁唑烷酮衍生物以及含有该衍生物的药物组合物 Oxazolidinone derivatives and pharmaceutical compositions containing the derivative
02/08/2012CN101648920B 用作组蛋白去乙酰酶抑制剂的三氟甲基酮类化合物及其用途 Used as a histone deacetylase inhibitor trifluoromethyl ketone compounds and their uses
02/08/2012CN101415687B 鞘氨醇-1-磷酸结合抑制物质 Sphingosine-1-phosphate binding-inhibiting substance
02/08/2012CN101287731B 二噁嗪取代的芳基酰胺和噁二嗪取代的芳基酰胺 Dioxazine-substituted aryl amide and oxadiazine substituted aryl amide
02/07/2012US8110681 Compounds for the treatment of spinal muscular atrophy and other uses
02/07/2012US8110591 2-aminoaryloxazole compounds as tyrosine kinase inhibitors
02/07/2012US8110588 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors
02/07/2012US8110574 Derivatives of 4-aminopiperidine and their use as a medicament
02/07/2012US8110573 Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases
02/07/2012US8110572 Inhibitors of protein kinases
02/07/2012US8110570 Modulators of acetyl-coenzyme A carboxylase and methods of use thereof
02/07/2012CA2663366C Compounds and compositions as protein kinase inhibitors
02/07/2012CA2648569C Pyridyl amide t-type calcium channel antagonists
02/07/2012CA2492404C Piperidinetriol derivatives as inhibitors of glycosylceramide synthase
02/07/2012CA2471044C Benzimidazole derivatives and their use as gnrh antagonists
02/02/2012WO2012016217A1 Ampk-activating heterocyclic compounds and methods for using the same
02/02/2012WO2012015972A1 Compositions and methods for inhibition of the jak pathway
02/02/2012WO2012015723A1 Sulfonamide compounds useful as cyp17 inhibitors
02/02/2012WO2012015265A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
02/02/2012WO2012015024A1 Ethinyl-pyrazole derivative
02/02/2012WO2012014994A1 Naphthalene derivative
02/02/2012WO2012014963A1 Condensed ring pyridine compound
02/02/2012WO2012014910A1 P2x4 receptor antagonist
02/02/2012WO2012013728A1 Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use
02/02/2012WO2012013716A1 Bicyclic acetyl-coa carboxylase inhibitors
02/02/2012WO2011130419A3 Broad spectrum antiviral and antiparasitic agents
02/02/2012WO2011057973A9 Oxazoline derivatives for treatment of cns disorders
02/02/2012US20120030841 Isoxazoline compounds for combating invertebrate pests
02/02/2012US20120029200 Stem Cell Differentiating Agents and Uses Therefor
02/02/2012US20120029199 Synthesis of enone intermediate
02/02/2012US20120029192 Pyrazole Derivatives
02/02/2012US20120029191 Novel processes for the preparation of cyclopropyl-amide derivatives
02/02/2012US20120029027 N-[(6-aza-bicyclo[3.2.1]oct-5-yl)-aryl-methyl]-heterobenzamide derivatives, preparation thereof, and therapeutic use of same
02/02/2012US20120028996 Novel oxime derivatives
02/02/2012US20120028983 Novel compound having 3-heteroarylpyrimidin-4-(3h)-one structure and pharmaceutical preparation containing same
02/02/2012US20120028981 Kinase Knockdown Via Electrophilically Enhanced Inhibitors
02/02/2012US20120028979 2-(piperidin-1-yl)-4-heterocyclyl-thiazole-5-carboxylic acid derivatives against bacterial infections
02/02/2012US20120028978 Substituted bicyclic hcv inhibitors
02/02/2012US20120028977 Subunit Selective NMDA Receptor Potentiators For The Treatment Of Neurological Conditions
02/02/2012US20120028974 Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases
02/02/2012US20120028970 Heteroarylthiomethyl pyridine derivative
02/02/2012US20120028969 Bicyclic acetyl-coa carboxylase inhibitors and uses thereof
02/02/2012US20120028963 Novel hydroxamate derivative, a production method for the same, and a pharmaceutical composition comprising the same
02/02/2012US20120028962 Fused heterocyclic ring compound
02/02/2012US20120028961 6 Substituted 2, 3,4,5 Tetrahydro-1H-Benzo[d]Azepines as 5-HT2c Receptor Agonist
02/02/2012US20120028959 Dihydroorotate dehydrogenase inhibitors
02/02/2012US20120028958 5-alkynyl-pyrimidines
02/02/2012US20120028956 Bicyclic mglur5 positive allosteric modulators and methods of making and using same
02/02/2012US20120028955 Bicyclic mglur5 positive allosteric modulators and methods of making and using same
02/02/2012US20120028954 Substituted Pyridine, Pyridazine, Pyrazine And Pyrimidine Compounds And Methods For Using The Same
02/02/2012US20120028953 Azetidine Derivatives
02/02/2012US20120028952 5-alkynyl-pyrimidines
02/02/2012US20120028951 Pyridazinone compounds
02/02/2012US20120028950 Substituted heterocyclylbenzylpyrazoles and use thereof
02/02/2012US20120028931 Heterocyclic m-glu5 antagonists
02/02/2012US20120028924 Chemical compounds
02/02/2012US20120028923 Compositions and methods for inhibition of the jak pathway
02/02/2012US20120028920 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders
02/02/2012US20120028907 Methods for identification of tumor phenotype and treatment
02/02/2012US20120027874 Compounds useful as inhibitors of atr kinase
02/02/2012US20120027842 Topical formulations of flap inhibitors for administration to an eye
02/02/2012US20120027777 Ljungan virus with improved replication characteristics
02/02/2012CA2809113A1 P2x4 receptor antagonist
02/02/2012CA2806821A1 Fused ring pyridine compound
02/02/2012CA2806341A1 Ampk-activating heterocyclic compounds and methods for using the same
02/02/2012CA2806008A1 Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use
02/02/2012CA2805078A1 Imidazole derivatives
02/02/2012CA2804199A1 Compositions and methods for inhibition of the jak pathway
02/01/2012EP2412372A1 2-Aminooxazole derivatives for use as TRPV1 antagonists for treating i.a. pain, inflammation, neurodegenerative diseases or gastrointestinal diseases
02/01/2012EP2411387A2 Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
02/01/2012EP2411386A1 Fluorophore-containing compounds and their use in the detection of phosphorylated (poly)peptides
02/01/2012EP2411385A1 Process for the preparation of propionic acid derivatives
02/01/2012EP2411384A1 Insecticidal compounds
02/01/2012EP2411382A1 Compounds as cannabinoid receptor ligands
02/01/2012EP2411376A1 Inhibitors of nf-kb
02/01/2012EP2411365A1 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
02/01/2012EP2411363A1 Substituted piperidines as par-1 antagonists
02/01/2012EP2411361A1 1,1,1-trifluoro-2-hydroxypropyl compounds
02/01/2012EP2411011A1 Novel aminopyridine derivatives having aurora a selective inhibitory action
02/01/2012EP2411001A1 P2x3, receptor antagonists for treatment of pain
02/01/2012EP2411000A1 Pyrrolidine compounds which inhibit beta-secretase activity and methods of use thereof
02/01/2012EP2410857A1 P2x3, receptor antagonists for treatment of pain
02/01/2012EP2410844A1 Inhibitors of hepatitis c virus replication
02/01/2012EP2410841A1 Substituted bicyclic hcv inhibitors
02/01/2012EP2265601B1 Pyridazine derivatives as factor xia inhibitors
02/01/2012EP2099793B1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
02/01/2012EP2064204B1 Inhibitors of 5 -lipoxygenase activating protein ( flap)
02/01/2012EP1937669B1 Novel benzopyran derivatives as potassium channel openers
02/01/2012EP1531810B1 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
02/01/2012CN102341392A Novel crystalline hydrate, amorphous and polymorphic forms of dihydro-benzoxazole-6-yl-acetamide derivative and processes for their preparation
02/01/2012CN102341389A Fluorine containing compounds and methods of use thereof
02/01/2012CN102341388A Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators
02/01/2012CN102341387A Tetrazoyl oxime derivative, salt thereof, and plant disease control agent
02/01/2012CN102341383A Inhibitors of Bruton's Tyrosine Kinase
02/01/2012CN102336750A Method for preparing Chiral pyridinebis(oxazoline) ligand
02/01/2012CN102336749A Allosteric modulators of metabotropic glutamate receptors
1 ... 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 ... 647